Company Search:
Advanced Search
Sponsored Links
Oasmia Pharmaceutical AB Company Snapshot
Oasmia Pharmaceutical AB operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oasmia Pharmaceutical AB with three other pharmaceutical manufacturers in Europe: Oncimmune Holdings PLC of the United Kingdom (2019 sales of £171,000.00 [US$221,215.86 ] of which 100% was Distribution of testing products), Diurnal Group PLC of the United Kingdom (£1.04 million [US$1.35 million] of which 100% was Alkindi), and Medincell SA which is based in France (1.44 million Euro [US$1.60 million] of which 100% was the conduct of research and development ).

Sales Analysis. Oasmia Pharmaceutical AB reported sales of SEK 1.98 million (US$207.50 thousand) for the fiscal year ending April of 2019. This represents a sharp decrease of 37.5% versus 2018, when the company's sales were SEK 3.17 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oasmia Pharmaceutical AB
  Stock Performance Chart for Oasmia Pharmaceutical AB
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 4.45
(Figures in Swedish Kronor)
1 Week 28.8%   13 Weeks 30.1%  
4 Weeks 25.9%   52 Weeks -50.6%  
Oasmia Pharmaceutical AB Key Data:
  Ticker: OASM Country: Sweden
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 1,980,000
(Year Ending Jan 2020).
Employees: 60
  Currency: Swedish Kronor Market Cap: 1,524,736,655
  Fiscal Yr Ends: April Shares Outstanding: 342,637,451
  Share Type: Closely Held Shares: 110,120,813
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.